Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers

Molecular and Cellular Proteomics

Volumn 12, Issue 5, 2013, Pages 1306-1318

  Xu, Jing ^a   Chen, Yanhua ^a   Zhang, Ruiping ^a   Song, Yongmei ^b   Cao, Jianzhong ^b   Bi, Nan ^b   Wang, Jingbo ^b   He, Jiuming ^a   Bai, Jinfa ^a   Dong, Lijia ^b   Wang, Luhua ^b   Zhan, Qimin ^b   Abliz, Zeper ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARBOXYLIC ACID; CARNITINE; CISPLATIN; DECANOYLCARNITINE; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE; OCTANOYLCARNITINE; STEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; MALE; METABOLITE; METABOLOMICS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; VALIDATION STUDY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CARNITINE; CASE-CONTROL STUDIES; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84877598859     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.022830     Document Type: Article

References (54)

1. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global Cancer Statistics, 2002. CA Cancer J. Clin. 55, 74-108 (Pubitemid 40372904)
2. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global Cancer Statistics. CA Cancer J. Clin. 61, 69-90
3. Vizcaino, A. P., Moreno, V., Lambert, R., and Parkin, D. M. (2002) Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int. J. Cancer 99, 860-868 (Pubitemid 34575705)
4. Yang, C. S. (1980) Research on esophageal cancer in China. Cancer Res. 40, 2633-2644
5. Wakatsuki, M., Suzuki, Y., Nakamoto, S., Ohno, T., Ishikawa, H., Kiyohara, H., Kiyozuka, M., Shirai, K., Nakayama, Y., and Nakano, T. (2007) Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy. J. Gastroenterol. Hepatol. 22, 715-719 (Pubitemid 46608376)
6. Okuno, T., Tamura, T., Yamamori, M., Chayahara, N., Yamada, T., Miki, I., Okamura, N., Kadowaki, Y., Shirasaka, D., Aoyama, N., Nakamura, T., Okumura, K., Azuma, T., Kasuga, M., and Sakaeda, T. (2007) Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese. Am. J. Clin. Oncol. 30, 252-257 (Pubitemid 46884144)
7. Kuwahara, A., Yamamori, M., Nishiguchi, K., Okuno, T., Chayahara, N., Miki, I., Tamura, T., Kadoyama, K., Inokuma, T., Takemoto, Y., Nakamura, T., Kataoka, K., and Sakaeda, T. (2010) Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/Iva esophageal squamous cell carcinoma. Int. J. Med. Sci. 7, 48-54
8. Kuwahara, A., Yamamori, M., Nishiguchi, K., Okuno, T., Chayahara, N., Miki, I., Tamura, T., Inokuma, T., Takemoto, Y., Nakamura, T., Kataoka, K., and Sakaeda, T. (2009) Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Int. J. Med. Sci. 6, 305-311
9. Nicholson, J. K., and Lindon, J. C. (2008) Metabonomics. Nature 455, 1054-1056
10. Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189
11. Fiehn, O. (2001) Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genomics 2, 155-168
12. Huang, Z. Z., Lin, L., Yao, G., Chen, Y. J., Yan, X. M., Xing, J. C., and Hang, W. (2011) Bladder cancer determination via two urinary metabolites: a biomarker pattern approach. Mol. Cell. Proteomics. 10, M111.007922
13. Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., Mckilligin, E., Mosedale, D. E., and Grainger, D. J. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR based metabonomics. Nat. Med. 8, 1439-1444 (Pubitemid 36019430)
14. Chen, T. L., Xie, G. X., Wang, X. Y., Fan, J., Qiu, Y. P., Zheng, X. J., Qi, X., Cao, Y., Su, M. M., Wang, X. Y., Xu, L. X., Yen, Y., Liu, P., and Jia, W. (2011) Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol. Cell. Proteomics. 10, M110.004945
15. Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J. D., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X. H., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C., and Chinnaiyan A. M. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914
16. Ganti, S., Taylor, S. L., Abu Aboud, O., Yang, J., Evans, C., Osier, M. V., Alexander, D. C., Kim, K., and Weiss, R. H. (2012) Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res. 72, 3471-3479
17. Xuan, J., Pan, G., Qiu, Y., Yang, L., Su, M., Liu, Y., Chen, J., Feng, G., Fang, Y., Jia, W., Xing, Q., and He, L. (2011) Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J. Proteome Res. 10, 5433-5443
18. Wu, H., Xue, R. Y., Lu, C. L., Deng, C. H., Liu, T. T., Zeng, H. Z., Wang, Q., and Shen, X. Z. (2009) Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J. Chromatogr. B 877, 3111-3117
19. Zhang, J., Liu, L., Wei, S., Gowda, G. A., Hammoud, Z., Kesler, K. A., and Raftery, D. (2011) Metabolomics study of esophageal adenocarcinoma. J. Thorac. Cardiovasc. Surg. 141, 469-475
20. Gika, H. G., Theodoridis, G. A., Wingate, J. E., and Wilson, I. D. (2007) Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J. Proteome Res. 6, 3291-3303 (Pubitemid 47310213)
21. Xu, J., Tian, Y. P., Chen, Y. H., Zhang, R. P., Yang, F., Song, Y. M., and Abliz, Z. (2011) Plasma preparation method for metabolomic analysis based on rapid resolution liquid chromatography-mass spectrometry. Chin. J. Anal. Chem. 39, 1793-1797
22. Smith, C. A., Want, E. J., O'maille, G., Abagyan, R., and Siuzdak, G. (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779-787 (Pubitemid 43228585)
23. Kose, F., Weckwerth, W., Linke, T., and Fiehn, O. (2001) Visualizing plant metabonomic correlation networks using clique-metabolite matrices. Bioinformatics 17, 1198-1208 (Pubitemid 33735346)
24. Chen, Y., Zhang, R., Song, Y., He, J., Sun, J., Bai, J., An, Z., Dong, L., Zhan, Q., and Abliz, Z. (2009) RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer. Analyst 134, 2003-2011
25. Chen, J., Zhao, X., Fritsche, J., Yin, P., Schmitt-Kopplin, P., Wang, W., Lu, X., Häring, H. U., Schleicher, E. D., Lehmann, R., and Xu, G. (2008) Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal. Chem. 80, 1280-1289 (Pubitemid 351272366)
26. Swets, J. A. (1988) Measuring the accuracy of diagnostic systems. Science 240, 1285-1293
27. Weinstein, J. N. (2008) A postgenomic visual icon. Science 319, 1772-1773
28. Robertson, D. G., Reily, M. D., and Baker, J. D. (2007) Metabonomics in pharmaceutical discovery and development. J. Proteome Res. 6, 526-539 (Pubitemid 46340156)
29. Bijlsma, S., Bobeldijk, L., Verheij, E. R., Ramaker, R., Kochhar, S., Macdonald, I. A., Van Ommen, B., and Smilde, A. K. (2006) Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation. Anal. Chem. 78, 567-574 (Pubitemid 43100391)
30. Eriksson, L., Johansson, E., Kettaneh-Wold, N., Trygg, J., Wikström, C., and Wold, S. (2006) Multivariate and Megavariate Data Analysis Part I: Basic Principles and Applications, Umetrics Academy, Sweden.
31. Wiklund, S., Johansson, E., Sjöström, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., Gottfries, J., Moritz, T., and Trygg, J. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80, 115-122 (Pubitemid 351448411)
32. Fernie, A.R., Trethewey, R.N., Krotzky, A.J., and Willmitzer, L. (2004) Metabolite profiling: from diagnostics to systems biology. Nat. Rev. Mol. Cell Biol. 5, 763-769 (Pubitemid 39208185)
33. Griffiths, W. J., Koal, T., Wang, Y., Kohl, M., Enot, D. P., and Deigner, H. P. (2010) Targeted Metabolomics for Biomarker Discovery. Angew. Chem. Int. Ed. 49, 5426-5445
34. Borum, P. R. (1996) Changing perspective of carnitine function and the need for exogenous cartnitine of patients treated with hemodialysis. Am. J. Clin. Nutr. 64, 976-977
35. Bremer, J. (1983) Carnitine-metabolism and functions. Physiol. Rev. 63, 1420-1480
36. Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L. X., Cai, S., and Jia, W. (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J. Proteome Res. 8, 4844-4850
37. Chen, J., Wang, W., Lv, S., Yin, P., Zhao, X., Lu, X., Zhang, F., and Xu, G. (2009) Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal. Chim. Acta 650, 3-9
38. Peluso, G., Nicolai, R., Reda, E., Benatti, P., Barbarisi, P., and Calvani, M. (2000) Cancer and anticancer therapy-induced modifications on metabolism meditated by carnitine system. J. Cell. Physiol. 182, 339-350 (Pubitemid 30054367)
39. Adlouni, H. A., Katrib, K., and Férard, G. (1988) Changes in carnitine in polymorphonuclear leukocytes, mononuclear cells, and plasma from patients with inflammatory disorders. Clin. Chem. 34, 40-43 (Pubitemid 18039406)
40. Sewell, A. C., and Böhles, H. J. (1995) Acylcarnitines in intermediary metabolism. Eur. J. Pediatr. 154, 871-877
41. Wang, J., Hudson, R., and Sintim, H.O. (2012) Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs. Future Med. Chem. 4, 1113-1151
42. Kishi, Y., Okudaira, S., Tanaka, M., Hama, K., Shida, D., Kitayama, J., Yamori, T., Aoki, J., Fujimaki, T., and Arai, H. (2006) Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J. Biol. Chem. 281, 17492-17500
43. Hoelzinger, D. B., Mariani, L., Weis, J., Woyke, T., Berens, T. J., Mcdonough, W. S., Sloan, A., Coons, S. W., and Berens, M. E. (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7, 7-16 (Pubitemid 40209466)
44. Kehlen, A., Englert, N., Seifert, A., Klonisch, T., Dralle, H., Langner, J., and Hoang-Vu, C. (2004) Expression, regulation and function of autotaxin in thyroid carcinomas. Int. J. Cancer 109, 833-838 (Pubitemid 38500739)
45. Yang, S. Y., Lee, J., Park, C. G., Kim, S., Hong, S., Chung, H. C., Min, S. K., Han, J. W., Lee, H. W., and Lee, H. Y. (2002) Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin. Exp. Metastasis 19, 603-608 (Pubitemid 35454570)
46. Zhao, Z., Xiao, Y., Elson, P., Tan, H., Plummer, S., Berk, M., Aung, P. P., Lavery, I. C., Achkar, J. P., Li, L., Casey, G., and Xu, Y. (2007) Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J. Clin. Oncol. 25, 2696-2701 (Pubitemid 47123176)
47. Mills G. B., and Moolenaar W. H. (2003) The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591 (Pubitemid 37328830)
48. Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., Schoonjans, K., Bianco, A. C., and Auwerx, J. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484-489 (Pubitemid 43152840)
49. 1H HR-MAS spectroscopy of biopsy tissues. Magn. Reson. Med. 60, 510-516
50. Walenta, S., and Mueller-Klieser, W. F. (2004) Lactate: mirror and motor of tumor malignancy. Semin. Radiat. Oncol. 14, 267-274 (Pubitemid 38903231)
51. Krebs, H. A., and Johnson, W. A. (1980) The role of citric acid in intermediate metabolism in animal tissues. FEBS Lett. 117, 148-156
52. Williamson, J. R., Scholz, R., and Browning, E. T. (1969) Control mechanisms of gluconeogenesis and ketogenesis. II. interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver. J. Biol. Chem. 244, 4617-4627
53. Heuberger, W., Berardi, S., Jacky, E., Pey, P., and Krähenbuhl, S. (1998) Increased urinary excretion of carnitine in patients treated with cisplatin. Eur J Clin Pharmacol. 54, 503-508 (Pubitemid 28487369)
54. Nakajima, Y., Ito, T., Maeda, Y., Ichiki, S., Kobayashi, S., Ando, N., Hussein, M. H., Kurono, Y., Sugiyama, N., and Togari, H. (2011) Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS. Brain Dev. 33, 816-823